The need for Group IIA secretory phospholipase A2 (sPLA2 treatment -IIA) inhibitors in inflammatory ocular disease treatment. Issue 4 (2018) - Liu, Michael X; LV, Chao; Feng, Jennifer S; Asbell, Penny A; Wei, Yi
No abstract available